Algo version: 0.98b
Rohto Pharmaceutical is listed at the PNK Exchange
Rohto Pharmaceutical [RPHCF]
PNK Sector: Consumer Defensive Industry:Household Personal Products

Is Rohto Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Rohto Pharmaceutical pays dividends. Last time was Sunday 1st of June 2025 where the investors holding the stock on Friday 28th of March 2025 were paid $0.10989 per share. Over the last 17 times between 2010 and 2025, Rohto Pharmaceutical has paid $0.812994 with an average of $0.05 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Rohto Pharmaceutical 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $13.25, you would have made a profit of $8.29 per share or 62.57%

We do not have enough data to give you this answer.

Rohto Pharmaceutical has no real debt, which is good in periods of high inflation. Rohto Pharmaceutical has a good net profit margin of 6.98% and should have high tolerances against inflation.

We have calculated the inflation risk for Rohto Pharmaceutical to be low [0.4 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.